AI investors should get ready for a BIG surprise

Ignore this at your own peril  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

August 31, 2026   |   Read online Dear Reader, Do you hold any of these AI stocks? Wall Street insider Jason Bodner — the man who called Nvidia at $4.50 — says today’s AI stocks are about to hit a wall. And a completely different group of AI firms… names Wall Street is starting to ignore… are about to take off. This has nothing to do with SpaceX… A new chatbot… Autonomous robots… Or anything you’re likely hearing about. It has to do with a brand-new “light-speed” device turning AI as we know it into “Accelerated AI”… Making it 100 times faster… And 100 times more energy efficient — right here, on Earth. Already, some of the biggest tech investors like Elon Musk, Mark Zuckerberg, Cathie Wood, and Bill Gates are moving money into it. Just to name a few… They’re all moving money to prepare for what’s coming. But you won’t hear anything about it in the mainstream news… In fact, TV pundits spent most of this past year talking about AI worries and its “existential risk” to jobs… Or arguing whether we’re in an AI bubble and when it would pop… That’s why most Americans won’t see it coming until it’s too late. Don’t be one of them… Because if you’re holding the wrong AI stocks when “Accelerated AI” goes mainstream… You could spend the next decade just trying to claw back to even… But if you make the one move Jason reveals in this urgent video message… The next 12 to 24 months could hand you bigger gains than the entire AI boom of the last three years. Click here to hear the full story and get ahead of the crowd. But hurry, because this opportunity won’t stay hidden much longer. We have so much to look forward to, Jeff Brown Founder & CEO, Brownstone Research P.S. Jason also shares details on 10 popular AI stocks he says you must dump before this shift goes mainstream. Names sitting in millions of 401(k)s, IRAs, and brokerage accounts. Click here to see if yours made the list. Monday's Bonus Story 3 Energy Stocks Raising Dividends as the Sector Surges Authored by Leo Miller. Article Published: 8/20/2026. Key Points The energy sector has led all S&P 500 sectors in 2026 with a total return above 40%, fueled by surging oil prices. BP, Excelerate Energy, and Occidental Petroleum recently raised their dividends while maintaining strong yields and sustainable payout ratios based on cash flow. Occidental Petroleum, a top Berkshire Hathaway holding, boosted its dividend about 8% after generating roughly $3 billion in free cash flow and cutting debt in Q2. Special Report: A Tiny Gold Property Borders Barrick's Massive Nevada Discoveries (From Wall Street Logic) Energy is the best-performing sector in 2026, and it is not even close. The S&P 500 energy sector has delivered a total return of more than 40% in 2026. Meanwhile, the next-best-performing sector, technology, has returned less than 30%. Large increases in energy commodity prices have benefited the sector, with West Texas Intermediate oil futures up more than 40% in 2026. While energy’s price performance may not always remain this strong, many companies in the sector offer solid dividend returns, making them appealing to investors. Move Your Money Here Before August 31st (Ad) TradeSmith CEO Keith Kaplan warns that AI's rapid rise has a dark side, threatening American jobs and livelihoods. He says now is the time to prepare before August 31st. TradeSmith has invested $17 million in AI tools and built a platform used by 180,000 traders worldwide. One user, Stephen, credits it with building a $2.95 million retirement portfolio. See where Kaplan says to move your money before August 31st The energy sector has also recently seen a wave of dividend increases, ranging from some of the biggest names in refining to companies operating in lesser-known market niches. Three companies boosting their payouts offer meaningful yields, solid dividend sustainability and strong performance in 2026. BP Boasts Over 4% Yield as Profits Rise 78% First up is one of the world’s best-known energy companies, BP (NYSE: BP). With a market capitalization of around $110 billion, BP is one of the 15 most valuable firms in the worldwide oil, gas and consumable fuels industry. The stock has performed well in 2026, generating a return of nearly 30%. Soaring oil prices have helped the company’s profits balloon. “Underlying profit” is the key performance metric BP references. It adjusts for fluctuations in the value of oil inventories. The figure rose strongly, increasing 78% year over year (YOY) in Q2. This came even as refining throughput declined 4% from Q1 because of planned facility maintenance. BP also announced a 4% increase to its quarterly dividend. While this boost is moderate, it adds to BP’s already strong dividend yield, which stands near 4.6% on a forward basis. This figure significantly exceeds the dividend yields of several U.S. oil giants, including Chevron (NYSE: CVX), which offers an approximately 3.5% yield. At first glance, BP’s dividend sustainability looks questionable, with its payout ratio near 100%. However, cash flow is often a better measure of dividend sustainability for capital-intensive companies. On that basis, BP’s payout ratio is just 21%, indicating that its dividend is well supported. Excelerate Energy Ups Dividend 12.5% as Shares Take Off Excelerate Energy (NYSE: EE) is a significant player in the liquefied natural gas (LNG) industry, with a market capitalization of more than $4 billion. The company’s floating storage and regasification units (FSRUs) convert LNG into natural gas, which then flows through pipeline infrastructure. Much of its demand comes from island nations that lack direct access to natural gas for uses such as heating. The stock has also delivered strong returns in 2026, gaining nearly 40%. Notably, the company posted adjusted EBITDA growth of 12% YOY last quarter. Excelerate raised its full-year adjusted EBITDA guidance to $490 million to $515 million, citing a strong first half. The company also continues to add capacity to meet demand, targeting the commercial deployment of its recently purchased Methane Patricia Camila unit in early 2028. Excelerate announced a hefty 12.5% dividend increase during its latest earnings report, raising its payout to 9 cents per quarter. Although the payout is not large, Excelerate’s forward dividend yield of nearly 1% provides a moderate income return. Meanwhile, Excelerate already has a very strong payout ratio of around 22%, and analysts expect the figure to improve to 16% based on next year’s earnings estimates. Top Berkshire Position Occidental Petroleum Issues Sizable Dividend Boost Occidental Petroleum (NYSE: OXY) is not necessarily a household energy name, but Berkshire Hathaway (NYSE: BRK.B) knows the company well. Berkshire invested $7.7 billion in OXY in Q1 2022, and it continues to be one of the firm’s largest holdings, even after Warren Buffett’s retirement. At around $12.9 billion, OXY accounted for 4.3% of Berkshire’s portfolio as of the end of Q2. In retirement, Buffett is likely smiling at OXY’s 2026 performance, with shares delivering a total return of more than 40%. Occidental posted robust financial results in Q2, generating around $3 billion in free cash flow. This was the company’s highest free cash flow total since late 2022. It also raised its full-year production guidance and reduced its principal debt by $1.5 billion from Q1, bringing it to its lowest level since Q2 2019. Occidental is adding to its dividend, increasing its quarterly payout by about 8%. The stock’s forward yield now stands at 1.8%, providing a solid stream of dividend income. Additionally, Occidental is in a strong position regarding dividend sustainability. Its payout ratio is only around 16%, while its cash flow-based payout ratio is near 10%. Occidental Watch Items: Capital Spending Decreases Post-2027, Berkshire Position Looking ahead, it will be important to see whether Occidental can achieve its $4 billion sustainable cash flow improvement target by 2030. The company expects to reach this goal through lower costs and reduced capital spending, making changes in these figures important to watch after 2027. Occidental expects capital spending of $5.5 billion to $5.9 billion in 2026 and $5.9 billion in 2027. Changes in Berkshire’s Occidental holding will also be notable. Since Q1 2025, Berkshire has consistently held around 265 million OXY shares. Changes in this figure could indicate whether Berkshire’s conviction in the company is strengthening or deteriorating. .   Update your email preferences or unsubscribe here © 2026 The Markets Daily | MarketBeat Media, LLC 345 N Reid Place #620 Sioux Falls, SD 57103, United States

Vulcan power

Whitney Tilson explains why Berkshire's new leadership may signal a major shift in America's energy future ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Unsubscribe

Editor's Note: Why did Warren Buffett hand the keys of Berkshire Hathaway to a man who cut his teeth at a tiny, little-known power company in the California desert? Whitney Tilson — who's studied Buffett for more than 25 years and attended 23 straight Berkshire annual meetings — believes the answer points to possibly the biggest energy story of the decade. And he's connected all the dots in a new presentation. Watch "Buffett's Last Big Bet" below.

---

Dear Reader,

Did Warren Buffett just tip his hand one last time?

Before stepping back this year, Buffett handed the keys of Berkshire Hathaway to a man who cut his teeth at a tiny power company in the California desert.

Whitney Tilson — who has studied Buffett's every move for more than 25 years — calls the strategy behind it "Project Vulcan."

And here's what makes it so remarkable:

The power source at its center runs 24 hours a day, in any weather... needs no fuel deliveries... and President Trump just locked in its tax credits through 2033, – even as wind and solar's were gutted.

In other words:

It may be the only clean energy source built for the AI era.

And here's why Whitney believes some of the companies positioned around it could be about to soar...

In Q4 this year – possibly as soon as October – the first commercial-scale plant supplying this power goes officially live.

And the moment this event happens, Whitney expects this niche corner of the energy market to go mainstream... and get flooded with institutional money.

Click here to get Whitney's 3 best plays to potentially profit.

Sincerely,

Matt Weinshenck
Publisher and Director of Research, Stansberry Research

P.S. Berkshire's new CEO started his career as a financial controller in a company that was acquired by Buffett over 25 years ago...

And this company was one of the earliest pioneers in mining this remarkable fuel.

Now he's the leader of Berkshire Hathaway – at a time when arguably the biggest investment opportunity in the world is discovering the energy source that can power AI technology.

Coincidence?

Whitney thinks that's unlikely.

And although Buffet and his successor got there early, there's still a window of opportunity to get in on this for yourself...

But the window is closing fast.

Click here now to get 3 of Whitney's best investment ideas.

 
 
 
 
 
 

---

Additional Reading from MarketBeat

Intuit’s Earnings Reset May Be More Pivot Than Plunge

By Jeffrey Neal Johnson. Article Posted: 8/28/2026.

Key Points

• Intuit beat fiscal fourth-quarter expectations, but its fiscal 2027 guidance signaled slower revenue growth.
• Intuit’s lower TurboTax pricing, new QuickBooks entry points and Mailchimp reporting change are part of a broader customer-growth reset.
• Intuit’s mid-market momentum, artificial intelligence adoption and capital returns provide support as investors reassess the stock’s valuation.
• Special Report: Forget SpaceX. Buy the company Musk can't replace.

When a deeply entrenched market leader sheds nearly half its value in a matter of months, the broader market often starts pricing in a structural breakdown. For software giant Intuit Inc. (NASDAQ: INTU), a year-to-date decline approaching 48% has left many investors questioning the durability of its flagship accounting and tax franchises.

Following a soft fiscal 2027 guidance update, Wall Street rushed to adjust price targets, citing competition in the do-it-yourself tax space and a sluggish outlook for Mailchimp. Looking beyond the headline, however, the pessimism reveals a different story.

Here’s Why Trump Won’t End The Iran War (Ad)

Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up.

One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing.

See the real reason this conflict may never fully end.

Uncover the real reason Trump may never end this war

Management is executing a deliberate, near-term operational reset designed to recapture top-of-funnel market share and realign its core accounting businesses. While this pivot is weighing on the valuation today, underlying double-digit growth in the mid-market ecosystem, combined with aggressive share repurchases and structural margin protection, suggests the market may be overdiscounting Intuit's fundamental durability.

Wall Street May Be Reading Intuit’s Reset Too Harshly

Navigating a corporate transition requires distinguishing between a broken business model and a misunderstood strategic pivot. Intuit recently closed out its fiscal 2026 with strong fourth-quarter results, delivering $4.35 billion in revenue and adjusted earnings of $4.03 per share, easily clearing consensus estimates.

The market reaction, however, was anchored entirely to the fiscal 2027 outlook. Management guided for top-line revenue growth of 9% to 10%, a notable deceleration from the 14% growth achieved in the prior year. The resulting sell-off dragged Intuit stock down to a forward price-to-earnings ratio near 16.4, a contraction for a company that has historically commanded a premium software multiple.

Valuation compression of this magnitude often implies permanent market share loss or deteriorating cash flows. Yet analyzing the mechanics of the newly issued guidance provides a different picture: management appears willing to accept short-term optical pain to secure long-term ecosystem dominance.

Intuit Takes the Short-Term Hit to Rebuild the Funnel

A significant portion of the earnings reset stems from a fundamental accounting realignment rather than a deterioration in cash flow. Intuit is no longer excluding stock-based compensation from its non-GAAP profitability metrics.

This shift creates an optical hit of approximately $5.81 per share to the upcoming year's guidance. While including stock-based compensation lowers reported non-GAAP earnings, it provides a more transparent view of true operating costs. Intuit management is actively mitigating dilution concerns by committing to reduce stock-based compensation to about 8% of total revenue by fiscal 2030.

Beyond the accounting adjustments, Intuit is aggressively overhauling its consumer tax strategy. Pricing pressure from low-cost competitors has steadily siphoned away quality do-it-yourself tax customers. In response, leadership is deliberately sacrificing near-term average revenue per customer to rebuild the top of the sales funnel.

By lowering initial pricing thresholds, TurboTax revenue growth will likely remain muted at around 2% to 3% in the upcoming fiscal year. Sacrificing immediate margins to acquire customers is a classic software-as-a-service playbook, provided Intuit can monetize those users elsewhere.

Intuit is proving it can do just that. The number of Credit Karma members filing through TurboTax rose approximately 50% year over year, demonstrating strong cross-platform cooperation. Acquiring a do-it-yourself tax customer at a lower margin can be highly profitable when that same customer subsequently uses Credit Karma for personal loans or credit cards.

This top-of-funnel strategy also extends to the business segment. The recent rollout of QuickBooks Free and QuickBooks Lite generated roughly 20,000 active or upgraded users within its first month. By capturing entrepreneurs at the very beginning of their business lifecycle, Intuit locks them into an ecosystem that can scale alongside their operational needs.

At the same time, Intuit is spinning Mailchimp out into a standalone reporting segment and bracing for flat growth as it absorbs higher effective prices and persistent churn. This move effectively isolates the slower-growth unit from the core operations.

The Business Segment Still Supports the Bull Case

While the consumer tax segment undergoes a pricing reset and Mailchimp faces restructuring, the core business-to-business ecosystem remains robust. Global Business Solutions revenue, excluding Mailchimp, expanded by roughly 20% in the fourth quarter. The most compelling fundamental data point lies within the mid-market segment, where combined customer growth across QuickBooks Online Advanced and Intuit Enterprise Suite reached roughly 28%.

This growth is partially fueled by a planned migration of legacy desktop users to cloud-based platforms. Optically, a decline in desktop revenue can look like customer churn, but it actually reflects a structural upgrade in lifetime customer value as users transition to higher-tier, recurring-revenue software.

Intuit is also quietly building a substantial economic moat through artificial intelligence (AI). An estimated 75% of Intuit Enterprise Suite customers now interact with Intuit AI agents monthly. Embedding artificial intelligence into daily accounting, payroll, and invoicing workflows creates exceptionally high switching costs.

Competitors attempting to lure away these mid-market clients face the challenge of replacing a highly automated, deeply integrated financial operating system. This level of stickiness helps justify the strategic patience required while Intuit resets its lower-end consumer funnels.

Intuit's Aggressive Capital Defense

Transitioning a highly scaled software platform requires capital discipline, especially when deliberately slowing top-line growth to acquire market share. To protect operating margins during this reset, Intuit executed an approximate 17% workforce reduction. These efficiency gains provide the financial padding necessary to redeploy capital into targeted sales, marketing, and product innovation without eroding the bottom line.

Management's confidence in forward cash flow generation is evident in its capital return program. Intuit authorized and executed approximately $5.5 billion in share repurchases over the last fiscal year, representing an almost 96% increase from the prior period. Paired with a 15% increase in the quarterly dividend, which now yields nearly 1.40% at a sustainable 29% payout ratio, Intuit is providing tangible downside protection for shareholders as the strategic pivot takes root.

Filing the Final Return on Intuit's Growth Strategy

The upcoming September investor day serves as the next major catalyst for Intuit. Management will have the opportunity to map out the precise return-on-investment timeline for its top-of-funnel customer acquisition strategy and demonstrate the monetization roadmap for its expanding artificial intelligence capabilities.

Investors analyzing the current landscape might view the severe valuation discount as a compelling entry point, provided Intuit continues executing its mid-market and cross-platform growth initiatives. While Wall Street focuses on the immediate sting of guidance resets and accounting shifts, the underlying metrics suggest Intuit is working to fortify a durable, highly cash-generative ecosystem built to compete through the next cycle of financial software.

---

Further Reading from MarketBeat Media

2 Biotech Stocks Shaping Up for Major Breakouts

Reported by Ryan Hasson. Publication Date: 8/22/2026.

Key Points

• Moderna's mRNA cancer vaccine, developed with Merck, succeeded in a late-stage melanoma trial, sending shares up 177% and boosting the broader biotech sector.
• Eli Lilly, the world's largest pharmaceutical company, is nearing a 52-week high driven by its GLP-1 franchise and new oral-drug pipeline catalyst.
• Natera has surged over 40% year to date on accelerating revenue growth and analyst support, though its rich valuation reflects a momentum-driven growth profile.
• Special Report: Forget SpaceX. Buy the company Musk can't replace.

The biotech sector just received the kind of catalyst that can define a cycle. On Wednesday, Moderna (NASDAQ: MRNA) stunned the market when its personalized mRNA cancer vaccine, developed with Merck (NYSE: MRK), became the first such therapy to succeed in a late-stage trial, reducing the risk of melanoma recurrence.

The stock closed up an astonishing 177%, and the implications extend far beyond a single company. The result represents a landmark validation of the broader mRNA platform and a potential turning point for cancer treatment itself.

Here’s Why Trump Won’t End The Iran War (Ad)

Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up.

One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing.

See the real reason this conflict may never fully end.

Uncover the real reason Trump may never end this war

The news landed as the sector was already surging. The iShares Biotechnology ETF (NASDAQ: IBB) is up about 25% year to date, with much of that growth coming in the last 30 days. During that period, the ETF hit a fresh 52-week high, demonstrating the kind of strength that tends to draw fresh money off the sidelines. With Moderna's breakthrough adding fuel to that momentum, biotech's leadership may only strengthen from here.

Two biotech names in particular have quietly built powerful uptrends throughout this run and now appear poised to break out: Eli Lilly (NYSE: LLY) and Natera (NASDAQ: NTRA).

Eli Lilly: The Pharma Giant Still Dominating Its Market

Eli Lilly is the world's largest pharmaceutical company by market capitalization, a $1.2 trillion healthcare titan anchored by its blockbuster GLP-1 franchise. Even at that scale, the stock continues to climb. It is up more than 15% year to date and jumped about 4% on Wednesday alone to close just below its 52-week high.

The freshest catalyst is Lilly's push into oral GLP-1 medications, a next-generation format that could dramatically expand the weight-loss and diabetes market beyond today's injectables. It could also open the door to hundreds of millions of new patients.

That opportunity builds on an already dominant foundation, as Lilly's existing treatments continue to outpace rival Novo Nordisk (NYSE: NVO) in sales growth. A company this size rarely has both entrenched market leadership and a genuine new growth vector at the same time, but Lilly has exactly that.

On the analyst front, Lilly holds a Moderate Buy consensus across 30 analysts, and its news sentiment score ranks among the strongest in large-cap healthcare. The stock hit a new 52-week high on Wednesday, breaking above a resistance level that had held firm for nearly three months. If the stock can hold above $1,250, a major prior resistance level, a significantly higher-timeframe breakout could be in the cards for this sector-leading giant.

Natera: The Genetic Testing Leader Firing on All Cylinders

Natera offers a very different profile: It is a fast-growing diagnostics innovator specializing in cell-free DNA testing across reproductive health, oncology and organ transplantation. Its Signatera cancer-monitoring assay has become a standout product, and the company sits directly in the path of the precision-medicine wave sweeping through healthcare.

Natera has soared more than 40% year to date, easily outpacing the sector benchmark. Since breaking out of its multimonth base in June, the stock has advanced powerfully on accelerating revenue growth, with annual sales now topping $2.3 billion.

The market is treating Natera as a genuine leader in its niche, and its status as a top-10 holding in the IBB underscores that standing.

Analysts remain constructive, with a Moderate Buy consensus from 22 analysts. Just last week, Citi reiterated a Buy rating on the stock and raised its price target from $315 to $365.

The one factor worth flagging is valuation. After such a run, Natera trades at a rich multiple of more than 20 times sales, making it a momentum-driven growth name rather than a value play. From a momentum perspective, however, the chart is shaping up for another potential breakout. Following its recent earnings report, the stock has spent several weeks consolidating near its 52-week high and building a tight base. If NTRA pushes through that high, it could signal a breakout, with further upward momentum potentially following as the uptrend continues to expand.

2 Leaders at a Pivotal Moment

What makes these two names compelling right now is timing. Both have already demonstrated strength through months of outperformance, and both enter this moment with sectorwide momentum at their backs following Moderna's historic breakthrough. Eli Lilly offers scale, dominance and a fresh oral-drug catalyst, while Natera brings explosive growth and leadership in precision diagnostics. With biotech breaking out as a group and these two stocks pressing against their highs, the setup is one worth watching closely. As always, the charts will tell the final story, but the fundamental and sector backdrop could hardly be more supportive.

Thank you for subscribing to Insider Trades Daily, which covers the most recent insider buying and selling activity from Wall Street CEO's, CFO's, COO's and other insiders.
 
This message is a paid advertisement sent on behalf of Stansberry Research, a third-party advertiser of InsiderTrades.com and MarketBeat.
 
 

This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Stansberry Research please click here.

 
 
If you need help with your newsletter, feel free to contact our U.S. based support team at contact@marketbeat.com.
 
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
 
© 2006-2026 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, S.D. 57103-7078. U.S.A..

 

Check This Out: [Free Report] The 11-Hour Options Guide for Beginners - trade and ticker included (From Base Camp Trading)